Skip to content

Accuray

Recent events

Recent events tied to this brand in public sources.

Back to profile10 entries

  1. 2021

    Accuray CFO Shig Hamamatsu announces resignation

    Accuray CFO Shig Hamamatsu announced his resignation to pursue an opportunity in another industry; he was to remain CFO through September 3, 2021, to help ensure a smooth transition.

  2. 2021

    Accuray appoints Brandy Green interim CFO

    Accuray announced the appointment of Vice President and Corporate Controller Brandy Green as interim CFO, effective September 4, 2021.

  3. 2021

    Accuray announces Suzanne Winter's promotion to president

    Accuray announced that Suzanne Winter had been promoted to president, effective July 1, 2021. In the role, she will also oversee global manufacturing operations, the service organization, and quality and regulatory affairs.

  4. 2021

    Accuray appoints Byron C. Scott to its board

    Accuray appointed Byron C. Scott to its Board of Directors, effective February 12, 2021.

  5. 2021

    Accuray receives FDA clearance for ClearRT imaging

    Accuray reported that it received FDA 510(k) clearance for ClearRT Helical kVCT Imaging for the Radixact System.

  6. 2020

    Accuray appoints Mike Leischer to lead the Americas region

    Accuray announced that it had appointed Mike Leischer as vice president and general manager of its Americas region, effective immediately. He will lead the region's commercial teams and its business strategy.

  7. 2020

    Accuray launches CyberKnife S7 System

    Accuray announced the launch of the CyberKnife S7 System, a radiation therapy device for stereotactic radiosurgery and stereotactic body radiation therapy.

  8. 2020

    Accuray launches CyberKnife S7 System

    Accuray announced that it had launched the CyberKnife S7 System, a robotic radiation therapy device for treating tumors and neurologic disorders.

  9. 2020

    Accuray updates fiscal 2020 adjusted EBITDA guidance

    Accuray reaffirmed its fiscal 2020 revenue guidance and raised its adjusted EBITDA guidance to a range of $21 million to $26 million, from the previous range of $19 million to $24 million.

  10. 2019

    Accuray reports fiscal 2020 first-quarter results

    Accuray reported its financial results for the first quarter of fiscal 2020, including revenue of $89.6 million and a net loss of $9.4 million.